Date Title Description PDF
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download

Pages

Date Title Description PDF
25 Feb 2026 Annual Corporate Governance Report The Company submits the Annual Corporate Governance Report for fiscal year 2025.   Download
25 Feb 2026 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2025 annual report regarding remuneration of the members of the Board of Directors. Download
18 Nov 2025 On business and financial situation The Company releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development Download
02 Oct 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2025 Download
04 Jul 2025 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2025 Download

Pages

Date Title Description PDF
08 Nov 2012 Composición Consejo de Administración Download
18 Sep 2012 Otros sobre negocio y situación financiera Download
26 Jul 2012 Información sobre resultados (2) Download
26 Jul 2012 Información sobre resultados Download
26 Jul 2012 Información financiera intermedia Download

Pages